You are here: Home » Companies » News
Business Standard

Lupin receives approval from USFDA for generic Apixaban tablets

The product is a generic version of Bristol-Myers Squibb Company's Eliquis tablets in the same strengths

Press Trust of India  |  New Delhi 

drugs
Photo: Shutterstock

Drug firm Monday said it has received a tentative nod from the health regulator to market its generic

The company has received the tentative approval from the United States Food and Drug Administration (USFDA) to market in the strengths of 2.5 mg and 5 mg, said in a filing to

The product is a generic version of Bristol-Myers Squibb Company's Eliquis tablets in the same strengths, it added.

Eliquis tablets 2.5 mg and 5 mg had annual sales of approximately $6,366 million in the US, added.

The tablets are used for reducing the risk of stroke and systemic embolism in non valvular atrial fibrillation, among other purposes.

Shares of Lupin Monday closed at Rs 815.05 per scrip on BSE, down 2.96 per cent from the previous close.

First Published: Mon, December 10 2018. 18:40 IST
RECOMMENDED FOR YOU